Christopher Brooke
Geschäftsführer bei SwanBio Therapeutics, Inc.
Vermögen: 165 734 $ am 30.04.2024
Aktive Positionen von Christopher Brooke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Geschäftsführer | 16.10.2023 | - |
Karriereverlauf von Christopher Brooke
Ehemalige bekannte Positionen von Christopher Brooke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AYTU BIOPHARMA, INC. | Geschäftsführer | 14.11.2022 | 13.10.2023 |
| Corporate Officer/Principal | 01.04.2021 | 14.11.2022 | |
| Rumpus Therapeutics | Gründer | - | - |
Ausbildung von Christopher Brooke
| Colgate University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Rumpus Therapeutics |
- Börse
- Insiders
- Christopher Brooke
- Erfahrung
